JTJu Tang

Ju Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ju Tang has a total of 3 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaofei Cao

    Department of General Surgery, Taizhou People’s Hospital, Taizhou Clinical Medical College of Nanjing Medical University, Medical School of Nantong University, No.366 Taihu Road, Taizhou, 225300, Jiangsu, China

    1 shared publication
  • Xiaoliang Mei

    Department of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong University, No. 210 Yingchun Road, Taizhou City, Jiangsu Province 225300, China

    1 shared publication
  • Zhenxiang Zhang

    Department of Joint Surgery, Taizhou People’s Hospital, Medical School of Nantong University, No. 210 Yingchun Road, Taizhou City, Jiangsu Province 225300, China

    1 shared publication

Latest Publications

  • Open Access

    Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty

    by Ju Tang, Wei Zhu, Xiaoliang Mei, Zhenxiang Zhang

    The onset of deep vein thrombosis (DVT) in patients after total hip arthroplasty (THA) may expand or enlarge and subsequently lead to significant mortality. The objective of this study was to investigate potential risk factors for DVT in patients after THA. Eligible patients with hip joint diseases who were scheduled for unilateral primary THA at our hospital were prospectively included into this study. The demographic and clinical features, preoperative plasma biomarkers were detailed, recorded, and compared. The multiple logistic regression analysis was used to evaluate potential risk factors for DVT. A total of 214 subjects were enrolled into our study cohort for the final analysis, and 23 of them have suffered DVT with an incidence of 9.5%. The performance of logistic regression analysis showed that preoperative expression of plasminogen activator inhibitor-1 (PAI-1) was an independent risk factor for the onset of DVT in patients after THA (OR 1.18, 95% CI 1.04–1.29; p = 0.011). Our study indicated preoperative plasma PAI-1 expression as an independent risk factor for DVT in patients who underwent THA.